Navigation Links
Bioheart, Inc. to Report Full Year 2007 Financial Results on Thursday, March 27, 2008
Date:3/20/2008

SUNRISE, Fla., March 20 /PRNewswire-FirstCall/ -- Bioheart, Inc. (Nasdaq: BHRT) will report financial results for the year ended December 31, 2007 after the close of the market on Thursday, March 27, 2008. The Company has scheduled a conference call for Thursday, March 27, 2008 at 4:30 p.m. Eastern to discuss these results.

Interested parties can access the call by dialing (877) 858-9308 or (706) 643-0580, or can listen via a live Internet web cast, which can be found at http://www.bioheartinc.com. A replay of the call is available via webcast at http://www.bioheartinc.com for 30 days or by playback at (800) 642-1687 or (706) 645-9291 through March 29, 2008. Please use conference id #: 39978839 for the replay.

About Bioheart, Inc.:

Bioheart, Inc. is a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage. Its lead product candidate, MyoCell(R), is an innovative clinical cell therapy designed to populate regions of scar tissue within a patient's heart with autologous muscle cells, or cells from the patient's body, for the purpose of improving cardiac function in chronic heart failure patients. The company's pipeline includes multiple product candidates for the treatment of heart damage, including Bioheart Acute Cell Therapy, an autologous, adipose cell treatment for acute heart damage, and MyoCell II with SDF-1(TM), a therapy utilizing autologous cells genetically modified to express additional growth factors.

MyoCell and MyoCell II with SDF-1 are registere
'/>"/>

SOURCE Bioheart, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Genetic Engineering & Biotechnology News reports on clinical trials in developing countries
2. NeurogesX to Report Fourth Quarter and Year-End 2007 Financial Results
3. Vion Reports 2007 Fourth Quarter and Year-End Results
4. AutoImmune Inc. Reports 2007 Fourth Quarter and Year End Financial Results
5. Renovis Reports Fourth Quarter and Full Year 2007 Financial Results
6. Warner Chilcott Reports the Death of Its Director James Andress
7. Nile Therapeutics Reports 2007 Fourth Quarter and Full Year Financial Results
8. Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results
9. Unigene Restates Policy on Analyst Reports
10. NPS Pharmaceuticals Reports 2007 Financial Results
11. Trubion Pharmaceuticals Inc. Reports Fourth-Quarter and Year-Ended 2007 Financial Results and Provides 2008 Financial Outlook

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ire/--BiotechfirmReplikinsLtd.,whichhasanalyzedthe...prediction,outbreak,andprogressofthecurrentH1N1pan...virus.ThenewdatashowsthatthelethalityoftheH1N1("Sw...ringthevirus,scurrentoutbreakinthespringof2009tore...1N1virus,infectivitycount,however,remainsincreased...
(Date:11/25/2009)...wire-Asia/--SinovacBiotechLtd.(SVA),aleadingdevel...uted,ajointventure(JV)agreementtoestablishSinovac(...heJVwillresearch,develop,produce,andcommercializeh...,andexperienceindevelopingandcommercializingworld-...hts,manufacturingfacilitiesand,establishedoperatin...
(Date:11/24/2009)...wire-FirstCall/--IES(Nasdaq: IESC ),aleadingnation...ervicesforthecommercial,industrialandresidentialma...hasbeenawardedacontractfromManhattanTorconJVtoinst...SL-4)replacementfacilityattheU.S.ArmyMedicalResear...rickinFrederick,Md. ,, ThenewUSAMRIIDreplacemen...
(Date:11/24/2009)...tario,Nov.24/PRNewswire-FirstCall/--DowAgroScience...dSeeds,adivisionofThompsonsLimitedofBlenheim,Ontar...oSciences,currentseedsbusinessasthecompanyanticipa...wAgroSciencesHerbicideTolerantTraitTechnologyincor...ture. ,, "Thisacquisitionbringstogethertwostron...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3
...Care International, Inc. , which makes the drug He...llion in sales for the quarter ended March 31. , ,...bnormally high levels of parathyroid hormone in pa...run about 75 percent. , ,The company had a marked ...st year, when it reported losses of $2.3 million o...
...tatives of the British Consulate-General, which is...nvestments, met Wisconsin companies on Tuesday for...tion. , ,"We,re looking for companies with complim...id Frank Phillips, vice consul for the Chicago of...s the partnership can leverage their products. Wis...
...oundry reported a net loss of $941,000 for the qu... million loss for the same period a year ago. , ,T...ediaSite video and presentation product, which inc...nue for the quarter was $2.1 million, compared to ...the 11th consecutive quarter of increased sales. ,...
Other Biology Technology:British, Wisconsin firms explore life-science opportunities together 2British, Wisconsin firms explore life-science opportunities together 3
(Date:11/25/2009)...professors recently received funding from the Nati... beneficial to understanding the environment. The ...wood, assistant professor in the Department of Bio...o separate research projects. , His first projec...s and Functions from the Leaf to the Landscape," w...
(Date:11/24/2009)...to understanding how sounds associated with Navy s...or if they hear it at all. , The same type of la... to detect flaws in the space shuttle,s behemoth s...ek inside the giant head of a whale. The scans are...a whale,s hearing anatomy using a breakthrough met...
(Date:11/24/2009)... Medical Toxicology (ACMT) have signed an agreemen...l of Medical Toxicology (JMT), the official journ...reviously published by the University of Pennsylva... , an international, peer-reviewed journal, is ded...dical toxicology. The quarterly journal focuses o...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2Rocket science leads to new whale discovery 2Springer and the American College of Medical Toxicology to work together 2Better control of carbon nanotube growth promising for future electronics 14325 1Better control of carbon nanotube growth promising for future electronics 14325 2Better control of carbon nanotube growth promising for future electronics 14325 3Duke Singapore scientists find new way to classify gastric cancers 58725 1Duke Singapore scientists find new way to classify gastric cancers 58725 2Crayhon Research Now Available Exclusively Through Emerson Ecologics 58723 1Crayhon Research Now Available Exclusively Through Emerson Ecologics 58723 2
...wo groups of researchers at Carnegie Mellon Univer... $10 million in grants from the U.S. Department of...tems. One is for apple growers and one is for oran... quality and lower production costs. , The system... fixed sites within the orchards to gather a multi...
...issue-engineered trachea (windpipe), utilising the...ransplanted into a young woman with a failing airw... the patient with a normally functioning airway, t...ts provide crucial new evidence that adult stem ce...ls, can offer genuine solutions to other serious i...
...y day brings news of an apparent breakthrough agai...itions like diabetes, but these rarely translate i... do clinical development usually takes well over a...nducted in highly fragmented groups focusing on sp...t turn out not to work properly or to have dangero...
Other Biology News:Carnegie Mellon developing automated systems to enable precision farming of apples, oranges 2Carnegie Mellon developing automated systems to enable precision farming of apples, oranges 3Adult stem cell breakthrough 2Adult stem cell breakthrough 3Systems biology brings hope of speeding up drug development 2Systems biology brings hope of speeding up drug development 3
Normal Chicken Serum from Equitech-Bio
Pig Serum Non-Sterile Trace-Hemolyzed from Pel-Freez Biologicals
Mouse Anti-Keap1 Monoclonal Antibody, Unconjugated, Clone 333116 from R&D Systems
Normal Guinea Pig Serum from Equitech-Bio
Biology Products: